提供者:上海雅吉生物科技有限公司 发布时间:2026/10/27 17:03:58 阅读次数:20次 进入该公司店铺
文章标题:Epigenetic Silencing of GPD1 by HDAC2 via H3K9 Deacetylation Promotes Head and Neck Squamous Cell Carcinoma Progression
作者列表:Xiang Li, Qing Wang, Jiecheng Zhang, Wenjun Zhao, Xinting Zheng
影响因子:3.5
期刊:EXPERIMENTAL CELL RESEARCH
发表时间:2026-4-8
DOI:10.1016/j.yexcr.2026.115018
文献主题:Abstract
Background
Head and neck squamous cell carcinoma (HNSCC) remains a lethal malignancy with its pathogenic mechanisms incompletely unraveled. This study interrogates the role of the HDAC2-GPD1 axis in driving HNSCC progression.
Methods
HDAC2 and GPD1 expression was analyzed in HNSCC tissues (IHC) and cell lines (RT-qPCR). TCGA-HNSCC dataset (520 tumors, 44 normal controls) was used for bioinformatics analysis of gene expression, correlation, and prognostic value. Stable HNSCC cell lines with HDAC2/GPD1 overexpression or knockout were established via lentiviral infection. CCK-8, Transwell, wound healing, and flow cytometry were performed to assess cell proliferation, invasion, migration and apoptosis in vitro. ChIP assays were conducted to verify the binding of HDAC2 to the GPD1 promoter and the H3K9ac modification of GPD1. Nude mice were implanted with modified FaDu cells to assess tumor growth via tumor measurements and HE analyses.
① 凡本网注明"来源:阿仪网"的所有作品,版权均属于阿仪网,未经本网授权不得转载、摘编或利 用其它方式使用。已获本网授 权的作品,应在授权范围内使用,并注明"来源:阿仪网"。违者本网将追究相关法律责任。
② 本信息由注册会员:上海雅吉生物科技有限公司发布并且负责版权等法律责任。
版权声明